Guixi Zheng

Guixi Zheng

Auto-generated profile, based on publicly available information

Guixi Zheng

Department of Clinical Laboratory, Qilu Hospital of Shandong University , No. 107, Wenhua West Road, Lixia District, Jinan Shandong Province 250012

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2015 in Journal of Ovarian Research
Verified
Journal Article
Open access
PDF file
YTYaping Tian
Yaping Tian
CWChuanxin Wang
Chuanxin Wang
LCLiming Cheng
Liming Cheng
AZAimin Zhang
Aimin Zhang
WLWen Liu
Wen Liu
QOQishui Ou
Qishui Ou
To determine reference intervals for serum levels of human epididymis protein 4 (HE4) in Chinese women. In this multicenter (n = 9) study, 618 healthy women, 767 patients with non-malignant diseases, and 951 patients with malignant tumors were enrolled. Serum levels of HE4 were measured in all patients using electrochemiluminescence immunoassays. The influence of age, menopause, malignancy status and other characteristics on the levels of HE4 was evaluated using univariate and multivariate analyses. Confidence intervals (2.5–97.5 %) were determined in different populations. There were significant differences in HE4 levels among groups with different ages, menopause or malignancy status. Higher levels of HE4 were detected in elder compared to younger, post- compare to pre- menopause and malignant compared to benign subjects. Multivariate analysis showed that menopause and malignancy status, as well as smoking and pelvic masses were independent factors involved in serum HE4 levels. In pre-menopause stage, the reference ranges of HE4 level were 29.30–68.79, 28.12–1284.83 and 34.75–981.91 pmol/L in healthy, benign and malignant populations, respectively. In post-menopause stage, the reference ranges are 35.96–114.43, 39.11–2208.70 and 39.40–1678.13 pmol/L for those populations. The present study has established the reference intervals of HE4 levels in pre- and post-menopause populations with different malignancy status.

1 February 2024 in Experimental Cell Research
Verified
Journal Article
Open access
SZShoucai Zhang
Shoucai Zhang
SLShichao Liu
Shichao Liu
CYCongbo Yue
Congbo Yue
YLYingjie Liu
Yingjie Liu
GZGuixi Zheng
Guixi Zheng
YZYi Zhang
Yi Zhang
This study aims to identify the potential necroptosis related genes (NRGs)-associated miRNAs signature and explore the impact on the prognosis of stomach adenocarcinoma (STAD). Employing rigorous methodologies, we utilized univariate Cox, Lasso and multivariate Cox regression analyses to develop a prognostic signature. Kaplan-Meier (K-M) and ROC curves were applied to assess the prognostic value of signature in a training group and an independent test group. Furthermore, we conducted Gene Set Enrichment Analysis (GSEA) for enrichment of tumor-related pathways. The risk score was calculated for each patient based on the expression of miRNAs which were enrolled in the signature. Patients were stratified into high- and low-risk groups. The immune cell infiltration and immunotherapy were compared between the two groups. Finally, the diagnostic potential of the miRNA was explored by RT-qPCR. We constructed a prognostic model based on 6 NRGs-associated miRNAs. K-M plots underscored superior survival outcomes in the low-risk group. GSEA results revealed the enrichment of several tumor-related pathways in the high-risk group. Notably, CD8+ T cells, Tregs and activated memory CD4+ T cells exhibited negative correlations with the risk score. Additionally, a few immune checkpoint genes, such as CTLA4, PD1 and PD-L1, were significantly upregulated in the low-risk group. Furthermore, the serum expression levels of all these 6 miRNAs were significantly elevated in STAD patients. Our study identified a robust risk score derived from a signature of 6 NRGs-associated miRNAs, demonstrating high efficacy for prognosis of STAD. These results not only contributed to our understanding of STAD pathogenesis, but also held promise for potential clinical applications, particularly in the realm of personalized immunotherapy for STAD patients.

30 June 2025 in Human Molecular Genetics
Verified
Journal Article
Closed access
SLShichao Liu
Shichao Liu
SZShoucai Zhang
Shoucai Zhang
HZHongxi Zhao
Hongxi Zhao
YLYingjie Liu
Yingjie Liu
ZZZeyu Zhang
Zeyu Zhang
GZGuixi Zheng
Guixi Zheng
DDX39B, a member of the DEAD-box (DDX) RNA helicase family, plays a pivotal role in the post-transcriptional regulation of diverse pathological processes, including tumor progression, viral replication, and neurodegenerative disorders. In this study, we investigated the functional significance of DDX39B in the proliferation and metastasis of colon adenocarcinoma (COAD) and sought to uncover its underlying molecular mechanism. Our findings revealed that DDX39B was markedly upregulated in COAD tumor tissues, and its elevated expression correlated with poor patient prognosis. Functional assays, both in vitro and in vivo, demonstrated that DDX39B substantially enhanced the proliferative and metastatic potential of COAD cells. Mechanistically, DDX39B expression was positively associated with Ki67 levels and was found to facilitate epithelial-mesenchymal transition (EMT) in COAD. As an RNA-binding protein (RBP), DDX39B increased the stability of DCLK1-B mRNA, a variant highly expressed in colorectal cancer known to promote cancer stemness, thereby augmenting its protein expression. Notably, silencing of DCLK1-B effectively abrogated the pro-metastatic effects induced by DDX39B overexpression. Collectively, our results offered novel insights into the oncogenic role of DDX39B and highlighted its potential as a therapeutic target in COAD.

15 June 2022 in Cancer Research
Verified
Journal Article
Open access
GZGuixi Zheng
Guixi Zheng
Alternative splicing (AS) events play a crucial role in the tumorigenesis and progression of cancer. Transcriptome data and Percent Spliced In (PSI) values of ovarian cancer patients were downloaded from TCGA database and TCGA SpliceSeq. Totally we identified 1,472 AS events that were associated with survival of ovarian serous cystadenocarcinoma (OV) and exon skipping (ES) was the most important type. Univariate and multivariate Cox regression analysis were performed to identify survival-associated AS events and developed the prognostic model based on 11-AS events. The immune cells and different response to cytotoxic T lymphocyte associated antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1) blockers in low-risk and high-risk group of OV patients were analyzed. Ten kinds of immune cells were found up-regulated in low-risk group. Activated B cell, natural killer T cell, natural killer cell and regulatory T cell were associated with survival of OV. The patients in low-risk group had good response to CTLA-4 and PD-1 blockers treatment. Moreover, a regulatory network was established according to the correlation between AS events and splicing factors (SFs). The present study provided valuable insights into the underlying mechanisms of OV. AS events that were correlated with the immune system might be potential therapeutic targets. Citation Format: Guixi Zheng. Comprehensive characterization of 11 prognostic alternative splicing events in ovarian cancer interacted with the immune microenvironment [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 5010.